Cerebral structural changes in diabetic kidney disease: African American-diabetes heart study MIND

Diabetes Care

Volumn 38, Issue 2, 2015, Pages 206-212

  Sink, Kaycee M ^a   Divers, Jasmin ^a   Whitlow, Christopher T ^a   Palmer, Nicholette D ^a   Smith, S Carrie ^a   Xu, Jianzhao ^a   Hugenschmidt, Christina E ^a   Wagner, Benjamin C ^a   Williamson, Jeff D ^a   Bowden, Donald W ^a   Maldjian, Joseph A ^a   Freedman, Barry I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CREATININE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; BRAIN ATROPHY; BRAIN SIZE; CEREBROSPINAL FLUID; CHRONIC KIDNEY DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; GRAY MATTER; HIPPOCAMPUS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; WHITE MATTER; WHITE MATTER LESION; WORKING MEMORY; AGED; ALBUMINURIA; ATROPHY; BRAIN; BRAIN DISEASE; CAUCASIAN; CHRONIC KIDNEY FAILURE; COGNITION DISORDERS; COMPLICATION; DIABETIC NEPHROPATHY; ETHNOLOGY; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; STATISTICAL MODEL;

ADULT; AFRICAN AMERICANS; AGED; ALBUMINURIA; ATROPHY; BLOOD GLUCOSE; BRAIN; BRAIN DISEASES; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC;

EID: 84921904600     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-1231     Document Type: Article

References (40)

1. Huang ES, Basu A, O'Grady M, Capretta JC. Projecting the future diabetes population size and related costs for the U. S. Diabetes Care 2009;32:2225-2229
2. Jacqmin-Gadda H, Alperovitch A, Montlahuc C, et al. 20-Year prevalence projections for dementia and impact of preventive policy about risk factors. Eur J Epidemiol 2013;28:493-502
3. Luchsinger JA. Type 2 diabetes and cognitive impairment: linking mechanisms. J Alzheimers Dis 2012;30(Suppl. 2):S185-S198
4. Kurella Tamura M, Muntner P, Wadley V, et al. Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States. Am J Kidney Dis 2011;58:756-763
5. Barzilay JI, Gao P, O'Donnell M, et al.; ONTARGET and TRANSCEND Investigators. Albuminuria and decline in cognitive function: the ONTARGET/TRANSCEND studies. Arch Intern Med 2011;171:142-150
6. Joosten H, Izaks GJ, Slaets JP, et al. Association of cognitive function with albuminuria and eGFR in the general population. Clin J Am Soc Nephrol 2011;6:1400-1409
7. Sajjad I, Grodstein F, Kang JH, Curhan GC, Lin J. Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol 2012;7:437-443
8. Weiner DE, Bartolomei K, Scott T, et al. Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis 2009;53:438-447
9. Bugnicourt JM, Godefroy O, Chillon JM, Choukroun G, Massy ZA. Cognitive disorders and dementia in CKD: the neglected kidneybrain axis. J Am Soc Nephrol 2013;24:353-363
10. Vogels SC, Emmelot-Vonk MH, Verhaar HJ, Koek HL. The association of chronic kidney disease with brain lesions on MRI or CT: a systematic review. Maturitas 2012;71:331-336
11. Khatri M, Wright CB, Nickolas TL, et al. Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). Stroke 2007;38:3121-3126
12. Van Harten B, De Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ. Brain imaging in patients with diabetes: a systematic review. Diabetes Care 2006;29:2539-2548
13. Den Heijer T, Vermeer SE, Van Dijk EJ, et al. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 2003;46:1604-1610
14. Jongen C, Van Der Grond J, Kappelle LJ, Biessels GJ, Viergever MA, Pluim JP; Utrecht Diabetic Encephalopathy Study Group. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia 2007;50:1509-1516
15. Kamiyama K, Wada A, Sugihara M, et al. Potential hippocampal region atrophy in diabetes mellitus type 2: a voxel-based morphometry VSRAD study. Jpn J Radiol 2010;28:266-272
16. Van Elderen SG, De Roos A, De Craen AJ, et al. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology 2010;75:997-1002
17. Moran C, Phan TG, Chen J, et al. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care 2013;36:4036-4042
18. Van Harten B, Oosterman J, Muslimovic D, Van Loon BJ, Scheltens P, Weinstein HC. Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing 2007;36:164-170
19. Craft S, Watson GS. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 2004;3:169-178
20. Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 2011;68:51-57
21. Dhikav V, Anand KS. Are vascular factors linked to the development of hippocampal atrophy in Alzheimer's disease? J Alzheimers Dis 2012;32:711-718
22. Divers J, Palmer ND, Lu L, et al. Admixture mapping of coronary artery calcified plaque in African Americans with type 2 diabetes mellitus. Circ Cardiovasc Genet 2013;6:97-105
23. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-318
24. Wechsler D. Adult Intelligence Scale. San Antonio, TX, Psychological Corp, 1997
25. Lezak MD. Neuropsychological Assessment. New York, NY, Oxford University Press, 1983
26. Ashburner J, Friston KJ. Voxel-based morphometrydthe methods. Neuroimage 2000;11:805-821
27. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273-289
28. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003;19:1233-1239
29. Schmidt P, Gaser C, Arsic M, et al. An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis. Neuroimage 2012;59:3774-3783
30. Maldjian JA, Whitlow CT, Saha BN, et al. Automated white matter total lesion volume segmentation in diabetes. AJNR Am J Neuroradiol 2013;34:2265-2270
31. Jovicich J, Czanner S, Han X, et al. MRIderived measurements of human subcortical, ventricular and intracranial brain volumes: reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. Neuroimage 2009;46:177-192
32. Han X, Jovicich J, Salat D, et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage 2006;32:180-194
33. Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612
34. Box GEP, Cox DR. An analysis of transformations. J R Stat Soc Series B Stat Methodol 1964;26:211-252
35. Knopman DS, Mosley TH Jr, Bailey KR, Jack CR Jr, Schwartz GL, Turner ST. Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships. J Neurol Sci 2008;271:53-60
36. Knopman DS. Invited commentary: albuminuria and microvascular disease of the brainda shared pathophysiology. Am J Epidemiol 2010;171:287-289
37. Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 2003;34:806-812
38. Wada M, Nagasawa H, Iseki C, et al. Cerebral small vessel disease and chronic kidney disease (CKD): results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci 2008;272:36-42
39. Wright CB, Festa JR, Paik MC, et al. White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke 2008;39:800-805
40. Divers J, Hugenschmidt C, Sink KM, et al. Cerebral white matter hyperintensity in African Americans and European Americans with type 2 diabetes. J Stroke Cerebrovasc Dis 2013;22:e46-e52